Details for New Drug Application (NDA): 020250
✉ Email this page to a colleague
The generic ingredient in HALFAN is halofantrine hydrochloride. Additional details are available on the halofantrine hydrochloride profile page.
Summary for 020250
Tradename: | HALFAN |
Applicant: | Glaxosmithkline |
Ingredient: | halofantrine hydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
Approval Date: | Jul 24, 1992 | TE: | RLD: | No |
Complete Access Available with Subscription